PUBLISHER: KBV Research | PRODUCT CODE: 1150563
PUBLISHER: KBV Research | PRODUCT CODE: 1150563
LAMEA Transdermal Drug Delivery Systems Market Size, Share & Industry Trends Analysis Report By Application, By Type of Delivery System, By Country and Growth Forecast, 2022 - 2028
The Latin America, Middle East and Africa Transdermal Drug Delivery Systems Market would witness market growth of 7.7% CAGR during the forecast period (2022-2028).
The medicine is kept in a reservoir that is impermeably covered on one side and has an adhesive that makes contact with the skin on the other in practically all transdermal patch designs. Some designs use medicine that has been dissolved in a fluid or reservoir based on the gel, which can make formulations easier and allow the incorporation of liquid chemical additives like ethanol. These designs typically consist of four layers: an adhesive layer, a semi-permeable layer that may operate as a rate-limiting barrier, a drug reservoir, and an impermeable backing membrane.
Other approaches simplify manufacturing by incorporating the medication into a rigid polymer matrix. By removing the semi-permeable membrane, matrix systems can have just two layers or three layers if the medicine is incorporated into the glue. The need for geriatric medications has greatly increased due to the increase in the worldwide population. Transdermal drug delivery devices aid in the regulated distribution of medications, enhancing the efficacy of geriatric medications. Furthermore, during the past few decades, there has been a marked rise in the number of people with chronic illnesses like arthritis, diabetes, and heart disease.
These chronic conditions are the main source of disability and fatalities worldwide. Due to these issues, more R&D is being done to improve the efficacy of medications. Additionally, people are becoming more informed about how to utilize certain medications. These elements have boosted the market growth for transdermal medication delivery systems.
The Middle East has experienced a sharp rise in wealth over the past ten years, particularly among Gulf Cooperation Council (GCC) nations. This extraordinary gain in income has been accompanied by quick changes in lifestyle that have led to a sharp increase in chronic disease. Over the following decades, the severity of diabetes is anticipated to increase as the Middle East experiences the biggest rise in the incidence of type 2 diabetes, with over 60 million diabetics by 2030. These factors have accelerated the demand for medications in the region which will ultimately establish the transdermal drug delivery systems market in these regions.
The Brazil market dominated the LAMEA Transdermal Drug Delivery Systems Market by Country in 2021; thereby, achieving a market value of $1,256.8 million by 2028. The Argentina market is exhibiting a CAGR of 8.2% during (2022 - 2028). Additionally, The UAE market would experience a CAGR of 7.4% during (2022 - 2028).
Based on Application, the market is segmented into Analgesics, Hormone Replacement Therapies, Hypertension, Motion Sickness, Smoking Cessation and Others. Based on Type of Delivery System, the market is segmented into Passive and Active. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Viatris Inc., Bayer AG, Boehringer Ingelheim GmbH, Endo International plc, GlaxoSmithKline plc, Johnson & Johnson, Novartis AG, Purdue Pharma L.P., Altaris and Hisamitsu Pharmaceutical Co. Inc.
Scope of the Study
Market Segments covered in the Report:
By Application
- Analgesics
- Hormone Replacement Therapies
- Hypertension
- Motion Sickness
- Smoking Cessation
- Others
By Type of Delivery System
- Passive
- Active
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Companies Profiled
- Viatris Inc.
- Bayer AG
- Boehringer Ingelheim GmbH
- Endo International plc
- GlaxoSmithKline plc
- Johnson & Johnson
- Novartis AG
- Purdue Pharma L.P.
- Altaris
- Hisamitsu Pharmaceutical Co. Inc.
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 LAMEA Transdermal Drug Delivery Systems Market, by Application
- 1.4.2 LAMEA Transdermal Drug Delivery Systems Market, by Type of Delivery System
- 1.4.3 LAMEA Transdermal Drug Delivery Systems Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market Composition and Scenario
- 2.1.1 Overview
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
Chapter 3. LAMEA Transdermal Drug Delivery Systems Market by Application
- 3.1 LAMEA Analgesics Market by Country
- 3.2 LAMEA Hormone Replacement Therapies Market by Country
- 3.3 LAMEA Hypertension Market by Country
- 3.4 LAMEA Motion Sickness Market by Country
- 3.5 LAMEA Smoking Cessation Market by Country
- 3.6 LAMEA Others Market by Country
Chapter 4. LAMEA Transdermal Drug Delivery Systems Market by Type of Delivery System
- 4.1 LAMEA Passive Market by Country
- 4.2 LAMEA Active Market by Country
Chapter 5. LAMEA Transdermal Drug Delivery Systems Market by Country
- 5.1 Brazil Transdermal Drug Delivery Systems Market
- 5.1.1 Brazil Transdermal Drug Delivery Systems Market by Application
- 5.1.2 Brazil Transdermal Drug Delivery Systems Market by Type of Delivery System
- 5.2 Argentina Transdermal Drug Delivery Systems Market
- 5.2.1 Argentina Transdermal Drug Delivery Systems Market by Application
- 5.2.2 Argentina Transdermal Drug Delivery Systems Market by Type of Delivery System
- 5.3 UAE Transdermal Drug Delivery Systems Market
- 5.3.1 UAE Transdermal Drug Delivery Systems Market by Application
- 5.3.2 UAE Transdermal Drug Delivery Systems Market by Type of Delivery System
- 5.4 Saudi Arabia Transdermal Drug Delivery Systems Market
- 5.4.1 Saudi Arabia Transdermal Drug Delivery Systems Market by Application
- 5.4.2 Saudi Arabia Transdermal Drug Delivery Systems Market by Type of Delivery System
- 5.5 South Africa Transdermal Drug Delivery Systems Market
- 5.5.1 South Africa Transdermal Drug Delivery Systems Market by Application
- 5.5.2 South Africa Transdermal Drug Delivery Systems Market by Type of Delivery System
- 5.6 Nigeria Transdermal Drug Delivery Systems Market
- 5.6.1 Nigeria Transdermal Drug Delivery Systems Market by Application
- 5.6.2 Nigeria Transdermal Drug Delivery Systems Market by Type of Delivery System
- 5.7 Rest of LAMEA Transdermal Drug Delivery Systems Market
- 5.7.1 Rest of LAMEA Transdermal Drug Delivery Systems Market by Application
- 5.7.2 Rest of LAMEA Transdermal Drug Delivery Systems Market by Type of Delivery System
Chapter 6. Company Profiles
- 6.1 Viatris, Inc.
- 6.1.1 Company Overview
- 6.1.2 Financial Analysis
- 6.1.3 Segmental and Regional Analysis
- 6.1.4 Research & Development Expense
- 6.1.5 Recent strategies and developments:
- 6.1.5.1 Approval:
- 6.2 Purdue Pharma L.P.
- 6.2.1 Company Overview
- 6.3 Bayer AG
- 6.3.1 Company Overview
- 6.3.2 Financial Analysis
- 6.3.3 Segmental and Regional Analysis
- 6.3.4 Research & Development Expense
- 6.4 Novartis AG
- 6.4.1 Company Overview
- 6.4.2 Financial Analysis
- 6.4.3 Segmental and Regional Analysis
- 6.4.4 Research & Development Expense
- 6.5 Boehringer Ingelheim International Gmbh
- 6.5.1 Company Overview
- 6.5.2 Financial Analysis
- 6.5.3 Regional & Segmental Analysis
- 6.5.4 Research & Development Expenses
- 6.6 GlaxoSmithKline PLC
- 6.6.1 Company Overview
- 6.6.2 Financial Analysis
- 6.6.3 Segmental and Regional Analysis
- 6.6.4 Research & Development Expense
- 6.7 Johnson & Johnson
- 6.7.1 Company Overview
- 6.7.2 Financial Analysis
- 6.7.3 Segmental &Regional Analysis
- 6.7.4 Research & Development Expenses
- 6.8 Endo International PLC
- 6.8.1 Company Overview
- 6.8.2 Financial Analysis
- 6.8.3 Segmental and Regional Analysis
- 6.8.4 Research & Development Expense
- 6.9 Altaris Capital Partners, LLC
- 6.9.1 Company Overview
- 6.9.2 Recent strategies and developments:
- 6.9.2.1 Acquisition and Mergers:
- 6.10. Hisamitsu Pharmaceutical Co. Inc.
- 6.10.1 Company Overview
- 6.10.2 Financial Analysis
- 6.10.3 Recent strategies and developments:
- 6.10.3.1 Approval:
LIST OF TABLES
- TABLE 1 LAMEA Transdermal Drug Delivery Systems Market, 2018 - 2021, USD Million
- TABLE 2 LAMEA Transdermal Drug Delivery Systems Market, 2022 - 2028, USD Million
- TABLE 3 LAMEA Transdermal Drug Delivery Systems Market by Application, 2018 - 2021, USD Million
- TABLE 4 LAMEA Transdermal Drug Delivery Systems Market by Application, 2022 - 2028, USD Million
- TABLE 5 LAMEA Analgesics Market by Country, 2018 - 2021, USD Million
- TABLE 6 LAMEA Analgesics Market by Country, 2022 - 2028, USD Million
- TABLE 7 LAMEA Hormone Replacement Therapies Market by Country, 2018 - 2021, USD Million
- TABLE 8 LAMEA Hormone Replacement Therapies Market by Country, 2022 - 2028, USD Million
- TABLE 9 LAMEA Hypertension Market by Country, 2018 - 2021, USD Million
- TABLE 10 LAMEA Hypertension Market by Country, 2022 - 2028, USD Million
- TABLE 11 LAMEA Motion Sickness Market by Country, 2018 - 2021, USD Million
- TABLE 12 LAMEA Motion Sickness Market by Country, 2022 - 2028, USD Million
- TABLE 13 LAMEA Smoking Cessation Market by Country, 2018 - 2021, USD Million
- TABLE 14 LAMEA Smoking Cessation Market by Country, 2022 - 2028, USD Million
- TABLE 15 LAMEA Others Market by Country, 2018 - 2021, USD Million
- TABLE 16 LAMEA Others Market by Country, 2022 - 2028, USD Million
- TABLE 17 LAMEA Transdermal Drug Delivery Systems Market by Type of Delivery System, 2018 - 2021, USD Million
- TABLE 18 LAMEA Transdermal Drug Delivery Systems Market by Type of Delivery System, 2022 - 2028, USD Million
- TABLE 19 LAMEA Passive Market by Country, 2018 - 2021, USD Million
- TABLE 20 LAMEA Passive Market by Country, 2022 - 2028, USD Million
- TABLE 21 LAMEA Active Market by Country, 2018 - 2021, USD Million
- TABLE 22 LAMEA Active Market by Country, 2022 - 2028, USD Million
- TABLE 23 LAMEA Transdermal Drug Delivery Systems Market by Country, 2018 - 2021, USD Million
- TABLE 24 LAMEA Transdermal Drug Delivery Systems Market by Country, 2022 - 2028, USD Million
- TABLE 25 Brazil Transdermal Drug Delivery Systems Market, 2018 - 2021, USD Million
- TABLE 26 Brazil Transdermal Drug Delivery Systems Market, 2022 - 2028, USD Million
- TABLE 27 Brazil Transdermal Drug Delivery Systems Market by Application, 2018 - 2021, USD Million
- TABLE 28 Brazil Transdermal Drug Delivery Systems Market by Application, 2022 - 2028, USD Million
- TABLE 29 Brazil Transdermal Drug Delivery Systems Market by Type of Delivery System, 2018 - 2021, USD Million
- TABLE 30 Brazil Transdermal Drug Delivery Systems Market by Type of Delivery System, 2022 - 2028, USD Million
- TABLE 31 Argentina Transdermal Drug Delivery Systems Market, 2018 - 2021, USD Million
- TABLE 32 Argentina Transdermal Drug Delivery Systems Market, 2022 - 2028, USD Million
- TABLE 33 Argentina Transdermal Drug Delivery Systems Market by Application, 2018 - 2021, USD Million
- TABLE 34 Argentina Transdermal Drug Delivery Systems Market by Application, 2022 - 2028, USD Million
- TABLE 35 Argentina Transdermal Drug Delivery Systems Market by Type of Delivery System, 2018 - 2021, USD Million
- TABLE 36 Argentina Transdermal Drug Delivery Systems Market by Type of Delivery System, 2022 - 2028, USD Million
- TABLE 37 UAE Transdermal Drug Delivery Systems Market, 2018 - 2021, USD Million
- TABLE 38 UAE Transdermal Drug Delivery Systems Market, 2022 - 2028, USD Million
- TABLE 39 UAE Transdermal Drug Delivery Systems Market by Application, 2018 - 2021, USD Million
- TABLE 40 UAE Transdermal Drug Delivery Systems Market by Application, 2022 - 2028, USD Million
- TABLE 41 UAE Transdermal Drug Delivery Systems Market by Type of Delivery System, 2018 - 2021, USD Million
- TABLE 42 UAE Transdermal Drug Delivery Systems Market by Type of Delivery System, 2022 - 2028, USD Million
- TABLE 43 Saudi Arabia Transdermal Drug Delivery Systems Market, 2018 - 2021, USD Million
- TABLE 44 Saudi Arabia Transdermal Drug Delivery Systems Market, 2022 - 2028, USD Million
- TABLE 45 Saudi Arabia Transdermal Drug Delivery Systems Market by Application, 2018 - 2021, USD Million
- TABLE 46 Saudi Arabia Transdermal Drug Delivery Systems Market by Application, 2022 - 2028, USD Million
- TABLE 47 Saudi Arabia Transdermal Drug Delivery Systems Market by Type of Delivery System, 2018 - 2021, USD Million
- TABLE 48 Saudi Arabia Transdermal Drug Delivery Systems Market by Type of Delivery System, 2022 - 2028, USD Million
- TABLE 49 South Africa Transdermal Drug Delivery Systems Market, 2018 - 2021, USD Million
- TABLE 50 South Africa Transdermal Drug Delivery Systems Market, 2022 - 2028, USD Million
- TABLE 51 South Africa Transdermal Drug Delivery Systems Market by Application, 2018 - 2021, USD Million
- TABLE 52 South Africa Transdermal Drug Delivery Systems Market by Application, 2022 - 2028, USD Million
- TABLE 53 South Africa Transdermal Drug Delivery Systems Market by Type of Delivery System, 2018 - 2021, USD Million
- TABLE 54 South Africa Transdermal Drug Delivery Systems Market by Type of Delivery System, 2022 - 2028, USD Million
- TABLE 55 Nigeria Transdermal Drug Delivery Systems Market, 2018 - 2021, USD Million
- TABLE 56 Nigeria Transdermal Drug Delivery Systems Market, 2022 - 2028, USD Million
- TABLE 57 Nigeria Transdermal Drug Delivery Systems Market by Application, 2018 - 2021, USD Million
- TABLE 58 Nigeria Transdermal Drug Delivery Systems Market by Application, 2022 - 2028, USD Million
- TABLE 59 Nigeria Transdermal Drug Delivery Systems Market by Type of Delivery System, 2018 - 2021, USD Million
- TABLE 60 Nigeria Transdermal Drug Delivery Systems Market by Type of Delivery System, 2022 - 2028, USD Million
- TABLE 61 Rest of LAMEA Transdermal Drug Delivery Systems Market, 2018 - 2021, USD Million
- TABLE 62 Rest of LAMEA Transdermal Drug Delivery Systems Market, 2022 - 2028, USD Million
- TABLE 63 Rest of LAMEA Transdermal Drug Delivery Systems Market by Application, 2018 - 2021, USD Million
- TABLE 64 Rest of LAMEA Transdermal Drug Delivery Systems Market by Application, 2022 - 2028, USD Million
- TABLE 65 Rest of LAMEA Transdermal Drug Delivery Systems Market by Type of Delivery System, 2018 - 2021, USD Million
- TABLE 66 Rest of LAMEA Transdermal Drug Delivery Systems Market by Type of Delivery System, 2022 - 2028, USD Million
- TABLE 67 key information - Viatris, Inc.
- TABLE 68 Key Information - Purdue Pharma L.P.
- TABLE 69 Key Information - Bayer AG
- TABLE 70 Key Information - Novartis AG
- TABLE 71 Key Information - Boehringer Ingelheim International GmbH
- TABLE 72 Key Information - GlaxoSmithKline PLC
- TABLE 73 Key information - Johnson & Johnson
- TABLE 74 Key Information - Endo International PLC
- TABLE 75 Key Information - Altaris Capital Partners, LLC
- TABLE 76 Key Information - Hisamitsu Pharmaceutical Co. Inc.
List of Figures
- FIG 1 Methodology for the research
